Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02488486Terminated
Open-label trial of propofol and remifentanil in postoperative sedation, sponsored by Hôpital Foch. Primary endpoint: Level of sedation at 6 hours. Started May 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02488486.